These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 21682970

  • 1. Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients.
    Diacon AH, Dawson R, Hanekom M, Narunsky K, Venter A, Hittel N, Geiter LJ, Wells CD, Paccaly AJ, Donald PR.
    Int J Tuberc Lung Dis; 2011 Jul; 15(7):949-54. PubMed ID: 21682970
    [Abstract] [Full Text] [Related]

  • 2. Delamanid for multidrug-resistant pulmonary tuberculosis.
    Gler MT, Skripconoka V, Sanchez-Garavito E, Xiao H, Cabrera-Rivero JL, Vargas-Vasquez DE, Gao M, Awad M, Park SK, Shim TS, Suh GY, Danilovits M, Ogata H, Kurve A, Chang J, Suzuki K, Tupasi T, Koh WJ, Seaworth B, Geiter LJ, Wells CD.
    N Engl J Med; 2012 Jun 07; 366(23):2151-60. PubMed ID: 22670901
    [Abstract] [Full Text] [Related]

  • 3. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.
    Chan SL, Yew WW, Ma WK, Girling DJ, Aber VR, Felmingham D, Allen BW, Mitchison DA.
    Tuber Lung Dis; 1992 Feb 07; 73(1):33-8. PubMed ID: 1326348
    [Abstract] [Full Text] [Related]

  • 4. The early bactericidal activity of anti-tuberculosis drugs: a literature review.
    Donald PR, Diacon AH.
    Tuberculosis (Edinb); 2008 Aug 07; 88 Suppl 1():S75-83. PubMed ID: 18762155
    [Abstract] [Full Text] [Related]

  • 5. The early bactericidal activity of amikacin in pulmonary tuberculosis.
    Donald PR, Sirgel FA, Venter A, Smit E, Parkin DP, Van de Wal BW, Mitchison DA.
    Int J Tuberc Lung Dis; 2001 Jun 07; 5(6):533-8. PubMed ID: 11409580
    [Abstract] [Full Text] [Related]

  • 6. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
    Liu Y, Matsumoto M, Ishida H, Ohguro K, Yoshitake M, Gupta R, Geiter L, Hafkin J.
    Tuberculosis (Edinb); 2018 Jul 07; 111():20-30. PubMed ID: 30029909
    [Abstract] [Full Text] [Related]

  • 7. Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patients.
    Diacon AH, Dawson R, Hanekom M, Narunsky K, Maritz SJ, Venter A, Donald PR, van Niekerk C, Whitney K, Rouse DJ, Laurenzi MW, Ginsberg AM, Spigelman MK.
    Antimicrob Agents Chemother; 2010 Aug 07; 54(8):3402-7. PubMed ID: 20498324
    [Abstract] [Full Text] [Related]

  • 8. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ, Sirgel FA, Parkin DP, van de Wal BW, Donald PR, Mitchison DA.
    S Afr Med J; 1996 Feb 07; 86(2):155-8. PubMed ID: 8619142
    [Abstract] [Full Text] [Related]

  • 9. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH, Patientia RF, Venter A, van Helden PD, Smith PJ, McIlleron H, Maritz JS, Donald PR.
    Antimicrob Agents Chemother; 2007 Aug 07; 51(8):2994-6. PubMed ID: 17517849
    [Abstract] [Full Text] [Related]

  • 10. Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis.
    Gillespie SH, Gosling RD, Uiso L, Sam NE, Kanduma EG, McHugh TD.
    J Antimicrob Chemother; 2005 Dec 07; 56(6):1169-71. PubMed ID: 16223939
    [Abstract] [Full Text] [Related]

  • 11. Phase II dose-ranging trial of the early bactericidal activity of PA-824.
    Diacon AH, Dawson R, du Bois J, Narunsky K, Venter A, Donald PR, van Niekerk C, Erondu N, Ginsberg AM, Becker P, Spigelman MK.
    Antimicrob Agents Chemother; 2012 Jun 07; 56(6):3027-31. PubMed ID: 22430968
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Profile of delamanid for the treatment of multidrug-resistant tuberculosis.
    Szumowski JD, Lynch JB.
    Drug Des Devel Ther; 2015 Jun 07; 9():677-82. PubMed ID: 25678771
    [Abstract] [Full Text] [Related]

  • 14. The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.
    Gosling RD, Uiso LO, Sam NE, Bongard E, Kanduma EG, Nyindo M, Morris RW, Gillespie SH.
    Am J Respir Crit Care Med; 2003 Dec 01; 168(11):1342-5. PubMed ID: 12917230
    [Abstract] [Full Text] [Related]

  • 15. The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis.
    Donald PR, Sirgel FA, Botha FJ, Seifart HI, Parkin DP, Vandenplas ML, Van de Wal BW, Maritz JS, Mitchison DA.
    Am J Respir Crit Care Med; 1997 Sep 01; 156(3 Pt 1):895-900. PubMed ID: 9310010
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial.
    von Groote-Bidlingmaier F, Patientia R, Sanchez E, Balanag V, Ticona E, Segura P, Cadena E, Yu C, Cirule A, Lizarbe V, Davidaviciene E, Domente L, Variava E, Caoili J, Danilovits M, Bielskiene V, Staples S, Hittel N, Petersen C, Wells C, Hafkin J, Geiter LJ, Gupta R.
    Lancet Respir Med; 2019 Mar 01; 7(3):249-259. PubMed ID: 30630778
    [Abstract] [Full Text] [Related]

  • 17. Early bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide in pulmonary tuberculosis patients.
    Paramasivan CN, Herbert D, Umapathy KC, Rahman F, Krishnamurthy PV, Prabhakar R.
    Indian J Med Res; 1994 Jul 01; 100():1-4. PubMed ID: 7927544
    [Abstract] [Full Text] [Related]

  • 18. 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.
    Diacon AH, Dawson R, von Groote-Bidlingmaier F, Symons G, Venter A, Donald PR, van Niekerk C, Everitt D, Winter H, Becker P, Mendel CM, Spigelman MK.
    Lancet; 2012 Sep 15; 380(9846):986-93. PubMed ID: 22828481
    [Abstract] [Full Text] [Related]

  • 19. Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis.
    Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Peloquin CA, Alsultan A, Thiel BA, Debanne SM, Boom WH, Diacon AH, Johnson JL.
    Antimicrob Agents Chemother; 2016 Nov 15; 60(11):6591-6599. PubMed ID: 27550361
    [Abstract] [Full Text] [Related]

  • 20. Bedaquiline and delamanid in combination for treatment of drug-resistant tuberculosis.
    Mohr E, Ferlazzo G, Hewison C, De Azevedo V, Isaakidis P.
    Lancet Infect Dis; 2019 May 15; 19(5):470. PubMed ID: 31034392
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.